Log in

CVE:HTLHamilton Thorne Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: C$1.21
52-Week Range N/A
Volume8,030 shs
Average Volume190,937 shs
Market CapitalizationC$165.83 million
P/E Ratio109.17
Dividend YieldN/A
Hamilton Thorne Ltd., together with its subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets. The company offers clinical lasers, such as LYKOS and ZILOS-tk lasers, as well as clinical laser software and hardware for clinical assisted reproduction; and research lasers, including XYRCOS and XYClone lasers for stem cell research, gene targeting, knock out mouse production, SCNT, ICSI, IVF, and assisted hatching applications, as well as Stiletto lasers for isolation of cells of interest, ablation of unwanted cells, and precision scoring of cell colonies. It also provides clinical sperm analysis (CASA) products comprising IVOS II Clinical and CEROS II Clinical, as well as Human Motility II and Dimensions II Strict Morphology software to clinics, hospitals, and assisted reproduction centers; animal and research CASA systems, and motility software packages; and various sperm analyzer options. In addition, the company offers sperm analysis accessories, such as accu-beads+ for use in counting procedures in semen analysis; 2X-CEL disposable semen analysis slides; IDENT Stains for determining sperm motility and concentration; VIADENT stain to determine viable sperm count, concentration, and percentage from a motile sample; and MiniTherm Stage Warmer for CASA and manual sperm motility analysis. Further, it offers IMSI-Strict, an automated software solution for live sperm morphology under high magnification; Oosight imaging system for research purposes; and CIVA, a custom software to capture images/video and annotate. The company sells its products to pharmaceutical and biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Hamilton Thorne Ltd. is based in Beverly, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.28 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices



Sales & Book Value

Annual SalesC$38.12 million
Book ValueC$0.30 per share



Market CapC$165.83 million
Next Earnings Date8/25/2020 (Estimated)
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive HTL News and Ratings via Email

Sign-up to receive the latest news and ratings for HTL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Hamilton Thorne (CVE:HTL) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Hamilton Thorne?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hamilton Thorne in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Hamilton Thorne

When is Hamilton Thorne's next earnings date?

Hamilton Thorne is scheduled to release its next quarterly earnings announcement on Tuesday, August 25th 2020.
View our earnings forecast for Hamilton Thorne

What price target have analysts set for HTL?

2 brokerages have issued 12-month price targets for Hamilton Thorne's shares. Their forecasts range from C$1.45 to C$1.80. On average, they anticipate Hamilton Thorne's stock price to reach C$1.63 in the next year.
View analysts' price targets for Hamilton Thorne

Has Hamilton Thorne been receiving favorable news coverage?

Press coverage about HTL stock has been trending very positive on Saturday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Hamilton Thorne earned a coverage optimism score of 4.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future.
View the latest news about Hamilton Thorne

Who are some of Hamilton Thorne's key competitors?

What other stocks do shareholders of Hamilton Thorne own?

Who are Hamilton Thorne's key executives?

Hamilton Thorne's management team includes the following people:
  • Ms. Meg Spencer, Co-Founder & Chairman
  • Mr. David B. Wolf, Pres, CEO & Director
  • Mr. Diarmaid H. Douglas-Hamilton, Co-Founder, Sr. VP of R&D, CTO, Corp. Sec. and Director
  • Mr. Michael W. Bruns, VP of Fin. & CFO (Age 62)
  • Dr. Fabian Sell, Chief Exec. Officer of Gynemed

What is Hamilton Thorne's stock symbol?

Hamilton Thorne trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HTL."

How do I buy shares of Hamilton Thorne?

Shares of HTL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Hamilton Thorne?

Hamilton Thorne has a market capitalization of C$0.00 and generates C$38.12 million in revenue each year.

What is Hamilton Thorne's official website?

The official website for Hamilton Thorne is www.hamiltonthorne.com.

How can I contact Hamilton Thorne?

Hamilton Thorne's mailing address is 100 Cummings Ctr Ste 465e, BEVERLY, MA 01915-6143, United States. The company can be reached via phone at +1-978-9212050.

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.